Detection of minimal residual disease by next generation sequencing in AL amyloidosis

• Shayna Sarosiek,
• Cindy Varga,
• Allison Jacob,
• Maria Teresa Fulciniti,
• Nikhil Munshi,
• Vaishali Sanchorawala

Affiliations

Shayna Sarosiek

Section of Hematology & Medical Oncology, Boston Medical Center

Cindy Varga

The John C Davis Myeloma and Amyloid Program, Tufts Medical Center

Allison Jacob

Adaptive Biotechnologies

Maria Teresa Fulciniti

Division of Hematologic Malignancies, Dana-Farber Cancer Institute

Nikhil Munshi

Division of Hematologic Malignancies, Dana-Farber Cancer Institute

Vaishali Sanchorawala

Section of Hematology & Medical Oncology, Boston Medical Center